Lipoprotein apheresis - Shortening of treatment intervals reduces cardiovascular events: Case reports.

CONCLUSIONS: The intensified treatment regimen resulted in an improvement in clinical symptoms and no further progression of atherosclerosis. In conclusion, shorter therapeutic Lp-apheresis intervals, at least temporarily, should be considered in patients who suffer from clinical and/or angiographic progression of atherosclerosis, despite maximal lipid lowering medication and weekly Lp-apheresis. PMID: 31818444 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31818444?dopt=Abstract

Source: Atherosclerosis Supplements - November 30, 2019 Category: Cardiology Authors: Berent T, Berent R, Sinzinger H Tags: Atheroscler Suppl Source Type: research